PF-Atlas › Clinical Trials › NCT03018041
The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation
Omacor · Phase 3
Registry ID
NCT03018041
Phase
Phase 3
Status
Completed
Drug / intervention
Omacor
Sponsor
Joe Chan
Start
2017-09-01
Enrollment
174
Locations
6
About this trial
This is a long-term intervention study on the effects of marine n-3 PUFAs in renal transplantation. Our hypothesis is that patients treated with marine n-3 PUFA supplementation will have less decline in kidney transplant function compared to patients treated with placebo.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03018041 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.